Summary

Symphony Ltd has reported a 39% year-on-year decline in standalone revenue for Q1 FY 25-26, primarily attributed to pronounced seasonal headwinds and a high base of the June 2024 quarter. Despite this, the company surpassed its earlier second-best summer season revenue. Standalone EBITDA margin declined by 11.7% due to product mix and reduced operating leverage. GSK China continued its robust growth momentum, while IMPCO Mexico experienced subdued performance. Symphony AU Australia posted its second consecutive quarter of year-on-year growth. The company is strategically revolutionizing the air cooler sector with the introduction of the ‘Air Force’ range and advancing growth across all-season and counter-seasonal product categories.

Key Highlights

1. 1

   39% decline in standalone revenue

2. 2

   Robust growth in GSK China

3. 3

   Subdued performance in IMPCO Mexico

4. 4

   Second consecutive quarter of year-on-year growth in Symphony AU Australia

5. 5

   Introduction of ‘Air Force’ range in air cooler sector

6. 6

   Advancing growth across all-season and counter-seasonal product categories